About Us
Excellence in Diagnostics. Engineered in Europe. Trusted Worldwide
For over two decades, Neomedica has engineered innovative, fully automated In Vitro Diagnostics (IVD) solutions that empower laboratories to deliver fast, accurate, and cost-effective results.
Pioneering Laboratory Diagnostics
Founded in 2000 in Niš, Serbia, Neomedica has evolved into a global IVD leader. Operating from our advanced manufacturing facility, our mission is to be Europe’s premier medical device manufacturer. We achieve this by engineering highly automated, user-friendly diagnostic systems across hematology, clinical chemistry, and immunodiagnostics that eliminate compromise.
The Science of Simplicity
Our R&D teams partner with leading scientific institutions to continuously advance medical technology. This drives our flagship NAISSA® Monotest Immunoanalyzer, which integrates all reagents and calibrators into a single barcoded cartridge—eliminating waste and analytical error across over 200 assay parameters. We extend this automation to our COPROSS stool analyzer and our secure, FHIR/HL7-compliant NeoLimsys laboratory management software.
Unyielding Quality and Compliance
We enforce a strict "zero compromise" policy for product safety and accuracy. Our production ecosystem is ISO 13485:2016 certified and operates under stringent GMP and GLP protocols. With proactive alignment to the European In Vitro Diagnostic Regulation (IVDR), our global partners receive CE-marked products backed by robust clinical evidence and risk management.
Delivering Health Across Continents
Neomedica’s distribution network supplies cutting-edge diagnostics to over 160 countries. From our commercial hub in Belgrade to our presence at global exhibitions like MEDICA and MEDLAB, we continuously forge international alliances. By establishing manufacturing joint ventures in key markets like Algeria and Egypt, we ensure resilient supply chains and localized diagnostic sovereignty.
